• 24th Edition Strategic Project & Portfolio Management for Pharma Conference - Frankfurt‚ Germany

  • Event organized by Marcus Evans
  • 17 - 19 January, 2024
  • Frankfurt
  • Innovation Events Event
  • Visit website

Event description

17-19 January, 2024| Frankfurt‚ Germany

Optimising tools and processes to drive PPM efficiency and steer high-efficiency projects

The Marcus Evans 24 th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 17-19 January 2024, in Frankfurt, Germany, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing the best methodologies, technologies, and organizational models. The event will
explore how you can maximize the value and resilience of your portfolio through the best practices in project prioritization and resource allocation, focusing on creating the ideal balance between risks and opportunities. All these topics and more will be discussed in an open and engaging environment, with plenty of networking and brainstorming during the interactive sessions. At the end, you’ll walk away with actionable insights on how to build effective management capabilities and navigate critical decisions.

Attending This Premier Marcus Evans Conference Will Enable You to:

Unlock the power of AI in project management
• Build a fully integrated portfolio management system to maximise value creation in real time
• Leverage PPM reporting and drive transparency across the organisation
• Drive PMO efficiency to steer high-efficiency projects
• Manage PPM for clinical trials and specialised therapeutics
• Optimise risk-return profile and overall value of the global drug pipeline

Best Practices and Case Studies from:

  • Michael Collins, Executive Director Research, Development and Device Project Management, CSL Behring, Switzerland
  • Gilles Brackman, Vice President of R&D, Flen Health, Belgium
  • Maciej Szymaszek, Senior Director, Global Portfolio & Project Management, AstraZeneca, Sweden
  • Gitana Vaičiulytė, PMO, Transformation Program Manager, Terumo Europe, Belgium
  • Tung Le, Portfolio manager, CEPI, Norway
  • Paul Shaw, Vice President, EPMO, Sosei Heptares, UK
  • Topics

  • Pharmaceuticals